NEW YORK (Reuters) - Express Scripts Inc will buy health insurer WellPoint Inc's NextRx prescription business for $4.68 billion, becoming the No. 2 U.S. pharmacy benefit manager while gaining more ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback